Defeating Randomness – Targeted Integration as a Boost for Biotechnology

Genetic modification of mammalian cells is a prerequisite for the production of recombinant proteins, virus like particles, and viruses. For most applications long-term stability of such modifications is needed. Apart from episomal approaches which have not yet been sufficiently explored, integration of transgenes into the chromosomal DNA of the host cell is regarded to be the method of choice. Due to strong influences of the chromosomal surroundings on the expression of transgenes, targeted integration has obvious advantages over classical random integration procedures. Site directed integration leads to predictable expression properties, circumvents screening, is fast and provides high safety and is therefore advantageous for the integration of transgenes. In this chapter recombinase mediated cassette exchange (RMCE) using heterologous recombinases is described as an efficient and reliable method to target (integrate and replace) transgenes by site directed engineering of defined chromosomal sites for recombinant protein and virus expression. This technique, however, requires that the site of interest has been tagged before by specific sequence motifs. Thus, the chapter highlights current and forthcoming methods to (find and) tag chromosomal sites in order to make RMCE possible. This includes screening of randomly integrated reporters and spontaneous or Zinc Finger Nuclease enhanced homologous recombination.

[1]  Stefan Glaser,et al.  Current issues in mouse genome engineering , 2005, Nature Genetics.

[2]  Fyodor D Urnov,et al.  Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases , 2007, Proceedings of the National Academy of Sciences.

[3]  S Chandrasegaran,et al.  Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Deist,et al.  Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. , 2000, Science.

[5]  A. F. Stewart,et al.  Engineering embryonic stem cells with recombinase systems. , 2006, Methods in enzymology.

[6]  K. Rajewsky,et al.  Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: A tool for efficient genetic engineering of mammalian genomes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Wei Yang,et al.  Crystal structure of the site-specific recombinase γδ resolvase complexed with a 34 by cleavage site , 1995, Cell.

[8]  H. Hauser,et al.  The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells. , 1991, Gene.

[9]  P. Seeburg,et al.  Codon‐improved Cre recombinase (iCre) expression in the mouse , 2002, Genesis.

[10]  A. Kingsman,et al.  Effects of stoichiometry of retroviral components on virus production. , 2000, The Journal of general virology.

[11]  N. Selevsek,et al.  Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  C. Logie,et al.  Ligand-regulated site-specific recombination. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Dull,et al.  kat: A high-efficiency retroviral transduction system for primary human T lymphocytes , 1994 .

[14]  D. Littman,et al.  Packaging system for rapid production of murine leukemia virus vectors with variable tropism , 1992, Journal of virology.

[15]  M. Magnuson,et al.  Efficient DNA cassette exchange in mouse embryonic stem cells by staggered positive‐negative selection , 2004, Genesis.

[16]  S. Goetze,et al.  Performance of Genomic Bordering Elements at Predefined Genomic Loci , 2005, Molecular and Cellular Biology.

[17]  T. Schlake,et al.  Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. , 1994, Biochemistry.

[18]  G. Felsenfeld,et al.  A 5′ element of the chicken β-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila , 1993, Cell.

[19]  C. Ryu,et al.  Characterization of chimeric antibody producing CHO cells in the course of dihydrofolate reductase-mediated gene amplification and their stability in the absence of selective pressure. , 1998, Biotechnology and bioengineering.

[20]  M. Cox,et al.  Directionality in FLP protein-promoted site-specific recombination is mediated by DNA-DNA pairing. , 1986, The Journal of biological chemistry.

[21]  G. Wahl,et al.  RMCE-ASAP: a gene targeting method for ES and somatic cells to accelerate phenotype analyses , 2006, Nucleic acids research.

[22]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[23]  N. Pavletich,et al.  Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A , 1991, Science.

[24]  Perseus I. Missirlis,et al.  A high-throughput screen identifying sequence and promiscuity characteristics of the loxP spacer region in Cre-mediated recombination , 2006, BMC Genomics.

[25]  J. Garcia,et al.  Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus , 1991, Journal of virology.

[26]  Jeffrey C. Miller,et al.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases , 2005, Nature.

[27]  T. Jensen,et al.  Regulated gene insertion by steroid-induced ΦC31 integrase , 2008, Nucleic acids research.

[28]  D. Gilbert,et al.  Homogeneous tetracycline‐regulatable gene expression in mammalian fibroblasts , 2000, Journal of cellular biochemistry.

[29]  G. Kollias,et al.  Position-independent, high-level expression of the human β-globin gene in transgenic mice , 1987, Cell.

[30]  A. Enjalbert,et al.  Regulation of Cre recombinase by ligand-induced complementation of inactive fragments. , 2003, Nucleic acids research.

[31]  C. Branda,et al.  Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. , 2004, Developmental cell.

[32]  S. Hacein-Bey,et al.  Thérapie génique des déficits immunitaires combinés sévères , 2000 .

[33]  Torbjörn Gräslund,et al.  Evolution of programmable zinc finger-recombinases with activity in human cells. , 2007, Journal of molecular biology.

[34]  B. Sauer,et al.  Bacteriophage P1 cre gene and its regulatory region. Evidence for multiple promoters and for regulation by DNA methylation. , 1986, Journal of molecular biology.

[35]  Y Takeuchi,et al.  High-titer packaging cells producing recombinant retroviruses resistant to human serum , 1995, Journal of virology.

[36]  H. Hauser,et al.  Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement. , 2001, Human gene therapy.

[37]  B. Andrews,et al.  The FLP recombinase of the 2μ circle DNA of yeast: Interaction with its target sequences , 1985, Cell.

[38]  M. Noyes,et al.  Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases , 2008, Nature Biotechnology.

[39]  Aram Akopian,et al.  Chimeric recombinases with designed DNA sequence recognition , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Calos,et al.  Site-specific chromosomal integration mediated by phiC31 integrase. , 2008, Methods in molecular biology.

[41]  K. Rajewsky,et al.  Vagaries of conditional gene targeting , 2007, Nature Immunology.

[42]  Eric C. Olivares,et al.  A phage integrase directs efficient site-specific integration in human cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Miller,et al.  Inhibitors of retrovirus infection are secreted by several hamster cell lines and are also present in hamster sera , 1993, Journal of virology.

[44]  S. Goff,et al.  A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.

[45]  A. Kingsman,et al.  A transient three-plasmid expression system for the production of high titer retroviral vectors. , 1995, Nucleic acids research.

[46]  P Chambon,et al.  Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. , 1997, Biochemical and biophysical research communications.

[47]  T. Hocking,et al.  Heritable Targeted Gene Disruption in Zebrafish Using Designed Zinc Finger Nucleases , 2008, Nature Biotechnology.

[48]  C. S. Raymond,et al.  High-Efficiency FLP and ΦC31 Site-Specific Recombination in Mammalian Cells , 2007, PloS one.

[49]  R. Naviaux,et al.  The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses , 1996, Journal of virology.

[50]  H. Niwa,et al.  An efficient system to establish multiple embryonic stem cell lines carrying an inducible expression unit , 2005, Nucleic acids research.

[51]  M. Cox,et al.  DNA recognition by the FLP recombinase of the yeast 2 mu plasmid. A mutational analysis of the FLP binding site. , 1988, Journal of molecular biology.

[52]  M. Carrondo,et al.  The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange. , 2006, Journal of biotechnology.

[53]  O. Danos,et al.  Retroviral particles produced from a stable human-derived packaging cell line transduce target cells with very high efficiencies. , 1997, Human gene therapy.

[54]  M. Griffiths,et al.  CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells , 2005, BMC biotechnology.

[55]  M. Kay,et al.  Molecular analysis of chromosomal rearrangements in mammalian cells after phiC31-mediated integration. , 2006, Human gene therapy.

[56]  B. Sauer,et al.  DNA recombination with a heterospecific Cre homolog identified from comparison of the pac-c1 regions of P1-related phages. , 2004, Nucleic acids research.

[57]  A. Bradley,et al.  Tools for targeted manipulation of the mouse genome. , 2002, Physiological genomics.

[58]  Y. Wang,et al.  Site-specific integration of targeted DNA into animal cell genomes. , 2000, Gene.

[59]  Dagmar Wirth,et al.  A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[60]  P Chambon,et al.  Ligand-activated site-specific recombination in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[61]  K. Yamamura,et al.  Negative selection with the Diphtheria toxin A fragment gene improves frequency of Cre-mediated cassette exchange in ES cells. , 2006, Journal of biochemistry.

[62]  H. Hauser,et al.  New Approaches towards ex vivo and in vivo Gene Therapy , 2000, Cells Tissues Organs.

[63]  B. Sauer,et al.  Segmental genomic replacement by Cre-mediated recombination: genotoxic stress activation of the p53 promoter in single-copy transformants. , 1997, Nucleic acids research.

[64]  J. Gordon,et al.  Inducible Gene Knockouts in the Small Intestinal and Colonic Epithelium* , 1999, The Journal of Biological Chemistry.

[65]  Dagmar Wirth,et al.  Road to precision: recombinase-based targeting technologies for genome engineering. , 2007, Current opinion in biotechnology.

[66]  G. Lee,et al.  Limitations to the Development of Humanized Antibody Producing Chinese Hamster Ovary Cells Using Glutamine Synthetase‐Mediated Gene Amplification , 2006, Biotechnology progress.

[67]  H. Hauser,et al.  Flp-mediated integration of expression cassettes into FRT-tagged chromosomal loci in mammalian cells. , 2004, Methods in molecular biology.

[68]  J. Beckmann,et al.  Genome-wide prediction of matrix attachment regions that increase gene expression in mammalian cells , 2007, Nature Methods.

[69]  K. Rajewsky,et al.  Stringent doxycycline dependent control of CRE recombinase in vivo. , 2002, Nucleic acids research.

[70]  B. Andrews,et al.  Site-specific recombination of yeast 2-micron DNA in vitro. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[71]  A. McMahon,et al.  Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase , 1998, Current Biology.

[72]  J. Hughes,et al.  Manipulating the Mouse Genome to Engineer Precise Functional Syntenic Replacements with Human Sequence , 2007, Cell.

[73]  A. Otte,et al.  Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. , 2006, Trends in biotechnology.

[74]  R. Hoess,et al.  The role of the loxP spacer region in P1 site-specific recombination. , 1986, Nucleic acids research.

[75]  F. Cosset,et al.  Retroviral retargeting by envelopes expressing an N-terminal binding domain , 1995, Journal of virology.

[76]  F. Cosset,et al.  Continuous high-titer HIV-1 vector production , 2003, Nature Biotechnology.

[77]  R Kuhn,et al.  Temporally and spatially regulated somatic mutagenesis in mice. , 1998, Nucleic acids research.

[78]  A. Fischer,et al.  Gene therapy of severe combined immunodeficiencies , 2002, Nature Reviews Immunology.

[79]  Dana Carroll,et al.  Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. , 2002, Genetics.

[80]  G. Winter,et al.  Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires. , 1993, Nucleic acids research.

[81]  T. Steitz,et al.  Crystal structure of the site-specific recombinase gamma delta resolvase complexed with a 34 bp cleavage site. , 1996, Cell.

[82]  M. Imhof,et al.  Development of stable cell lines for production or regulated expression using matrix attachment regions. , 2001, Journal of biotechnology.

[83]  G. Wahl,et al.  Reproducible doxycycline-inducible transgene expression at specific loci generated by Cre-recombinase mediated cassette exchange , 2005, Nucleic acids research.

[84]  M. Bibikova,et al.  Efficient Gene Targeting in Drosophila With Zinc-Finger Nucleases , 2006, Genetics.

[85]  A. Schambach,et al.  Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells , 2007, Blood.

[86]  D. Ow,et al.  Site-specific cassette exchange and germline transmission with mouse ES cells expressing φC31 integrase , 2003, Nature Biotechnology.

[87]  R. Kingston,et al.  Amplification Using CHO Cell Expression Vectors , 2002, Current protocols in molecular biology.

[88]  B. Mosinger,et al.  Targeted oncogene activation by site-specific recombination in transgenic mice. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[89]  David A Wright,et al.  High-frequency homologous recombination in plants mediated by zinc-finger nucleases. , 2005, The Plant journal : for cell and molecular biology.

[90]  Yan Li,et al.  An efficient and targeted gene integration system for high-level antibody expression. , 2007, Journal of immunological methods.

[91]  G. Yarranton Mammalian recombinant proteins: vectors and expression systems. , 1990, Current opinion in biotechnology.

[92]  P. Angrand,et al.  Improved properties of FLP recombinase evolved by cycling mutagenesis , 1998, Nature Biotechnology.

[93]  Aram Akopian,et al.  Site-specific DNA recombinases as instruments for genomic surgery. , 2005, Advances in genetics.

[94]  R. Hoess,et al.  P1 site-specific recombination: nucleotide sequence of the recombining sites. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[95]  G. Stamatoyannopoulos,et al.  A chromatin insulator protects retrovirus vectors from chromosomal position effects. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[96]  F. Bushman,et al.  Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences , 2004, PLoS biology.

[97]  A. Berns,et al.  Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[98]  L. Leinwand,et al.  A genetic screen identifies novel non-compatible loxP sites. , 2002, Nucleic acids research.

[99]  J. Broach,et al.  Identification of the crossover site during FLP-mediated recombination in the Saccharomyces cerevisiae plasmid 2 microns circle , 1986, Molecular and cellular biology.

[100]  Margaret C. M. Smith,et al.  In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[101]  H. Cremer,et al.  Conditional Transgenesis Using Dimerizable Cre (DiCre) , 2007, PloS one.

[102]  Jeremy M Berg,et al.  Binding of two zinc finger nuclease monomers to two specific sites is required for effective double-strand DNA cleavage. , 2005, Biochemical and biophysical research communications.

[103]  N. Henderson,et al.  Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[104]  Dana Carroll,et al.  Targeted mutagenesis using zinc-finger nucleases in Arabidopsis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[105]  R. Mulligan,et al.  Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[106]  Lei Chen,et al.  Retroviral pseudotransduction for targeted cell manipulation. , 2004, Molecular cell.

[107]  Generation of mammalian cells with conditional expression of crerecombinase , 1997 .

[108]  T. Schlake,et al.  Scaffold/matrix-attached regions: structural properties creating transcriptionally active loci. , 1995, International review of cytology.

[109]  J. Bode,et al.  Coping with kinetic and thermodynamic barriers: RMCE, an efficient strategy for the targeted integration of transgenes. , 2001, Current opinion in biotechnology.

[110]  D. Kioussis,et al.  Locus Control Region Function and Heterochromatin-Induced Position Effect Variegation , 1996, Science.

[111]  S. Dymecki A modular set of Flp, FRT and lacZ fusion vectors for manipulating genes by site-specific recombination. , 1996, Gene.

[112]  G. Felsenfeld,et al.  Stopped at the border: boundaries and insulators. , 1999, Current opinion in genetics & development.

[113]  G. Wahl,et al.  Recombinase-mediated gene activation and site-specific integration in mammalian cells. , 1991, Science.

[114]  A. Tolstrup,et al.  Production of target‐specific recombinant human polyclonal antibodies in mammalian cells , 2006, Biotechnology and bioengineering.

[115]  Toni Cathomen,et al.  Custom Zinc-Finger Nucleases for Use in Human Cells , 2005 .

[116]  Luigi Naldini,et al.  Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery , 2007, Nature Biotechnology.

[117]  D. Roden,et al.  Recombinase‐mediated cassette exchange to rapidly and efficiently generate mice with human cardiac sodium channels , 2006, Genesis.

[118]  A. Otte,et al.  Identification of anti-repressor elements that confer high and stable protein production in mammalian cells , 2003, Nature Biotechnology.

[119]  G. Lee,et al.  Key Determinants in the Occurrence of Clonal Variation in Humanized Antibody Expression of CHO Cells during Dihydrofolate Reductase Mediated Gene Amplification , 2001, Biotechnology progress.

[120]  I. Saito,et al.  Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination. , 1998, Gene.

[121]  Morgan L. Maeder,et al.  Comparison of zinc finger nucleases for use in gene targeting in mammalian cells. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[122]  Dana Carroll,et al.  Gene targeting using zinc finger nucleases , 2005, Nature Biotechnology.

[123]  D. Schübeler,et al.  Retargeting of retroviral integration sites for the predictable expression of transgenes and the analysis of cis-acting sequences. , 1998, Biochemistry.

[124]  H. Albert,et al.  Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome. , 1995, The Plant journal : for cell and molecular biology.

[125]  David Baltimore,et al.  Chimeric Nucleases Stimulate Gene Targeting in Human Cells , 2003, Science.

[126]  A. Ballabio,et al.  Tagging genes with cassette-exchange sites , 2005, Nucleic acids research.

[127]  Y. Kanegae,et al.  Production of viral vectors using recombinase-mediated cassette exchange , 2005, Nucleic acids research.

[128]  T. Shibui,et al.  Construction of engineered CHO strains for high-level production of recombinant proteins , 2002, Applied Microbiology and Biotechnology.

[129]  D J Segal,et al.  Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[130]  R. Awatramani,et al.  Ligand‐activated Flpe for temporally regulated gene modifications , 2005, Genesis.

[131]  Yang Du,et al.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 , 2006, Nature Medicine.